Bio-Path Holdings, Inc. (BPTH)
OTCMKTS · Delayed Price · Currency is USD
0.0003
-0.0003 (-50.00%)
At close: Oct 15, 2026
Bio-Path Holdings Market Cap
Bio-Path Holdings has a market cap or net worth of $16.17 thousand as of October 16, 2026. It is the 51,428th most valuable company in the world and the 7,503rd biggest in the United States. Its market cap has decreased by 97.43% in one year.
Market Cap
16.17K
Enterprise Value
535.17K
Revenue
n/a
Global Rank
Country Rank
#7,503 United States
PE Ratio
n/a
ChartMarket Cap Chart
Since February 15, 2008, Bio-Path Holdings's market cap has decreased from 31.22M to 16.17K, a decrease of -99.95%. That is a compound annual growth rate of -33.31%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 15, 2026 | 16.17K | -97.08% |
| Dec 31, 2025 | 554.53K | -88.90% |
| Dec 31, 2024 | 5.00M | -12.65% |
| Dec 29, 2023 | 5.72M | -52.42% |
| Dec 30, 2022 | 12.02M | -55.47% |
| Dec 31, 2021 | 26.99M | 69.81% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Burzynski Research Institute | 26.29K |
| Biostax | 21.65K |
| Carisma Therapeutics | 20.92K |
| Health Sciences Group | 20.51K |
| Scopus BioPharma | 16.83K |
| Panbela Therapeutics | 14.57K |
| IO Biotech | 14.39K |
| Vaxxinity | 12.68K |